Endocapsular equator rings prevent posterior capsular opacification

Article

The 9.5 mm E-ring prevents posterior capsular opacification (PCO) in patients after cataract surgery.

An investigation published in the Archives of Ophthalmology shows that the 9.5 mm E-ring prevents posterior capsular opacification (PCO) in patients after cataract surgery.

Dr Tsutomu Hara et al., Hara Eye Hospital, Utsunomiya, Japan, studied 51 eyes that underwent cataract surgery and E-ring implantation. The patients were divided into three groups. Group 1 consisted of 14 patients who received an E-ring and IOL in one eye and just an IOL in the fellow eye. Group 2 included 37 eyes of 23 patients who received an E-ring and IOL in one or both eyes and 37 age-matched control eyes who received an IOL implant only. There was a follow-up period of 2 to 7 years and the PCO value was assessed using the Hayashi method.

The results found that, 2 years postoperatively, the PCO value in the central area of the eyes with an E-ring were considerably lower in group 1 than in the control eyes.

Patients who received an E-ring did not require additional postoperative Nd:YAG laser posterior capsulotomy compared with 23 of the 51 control eyes.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
© 2025 MJH Life Sciences

All rights reserved.